A mathematical model of the dynamics of prion aggregates with chaperone-mediated fragmentation
Tóm tắt
Prions are proteins most commonly associated with fatal neurodegenerative diseases in mammals but are also responsible for a number of harmless heritable phenotypes in yeast. These states arise when a misfolded form of a protein appears and, rather than be removed by cellular quality control mechanisms, persists. The misfolded prion protein forms aggregates and is capable of converting normally folded protein to the misfolded state through direct interaction between the two forms. The dominant mathematical model for prion aggregate dynamics has been the nucleated polymerization model (NPM) which considers the dynamics of only the normal protein and the aggregates. However, for yeast prions the molecular chaperone Hsp104 is essential for prion propagation. Further, although mammals do not express Hsp104, experimental assays have shown Hsp104 also interacts with mammalian prion aggregates. In this study, we generalize the NPM to account for molecular chaperones and develop what we call the enzyme-limited nucleated polymerization model (ELNPM). We discuss existence, uniqueness and stability of solutions to our model and demonstrate that the NPM represents a quasi-steady-state reduction of our model. We validate the ELNPM by demonstrating agreement with experimental results on the yeast prion
$$[$$
PSI
$${}^{+}]$$
that could not be supported by the NPM. Finally, we demonstrate that, in contrast to the NPM, the ELNPM permits the coexistence of multiple prion strains.
Tài liệu tham khảo
Aguzzi A, Polymenidou M (2004) Mammalian prion biology: one century of evolving concepts. Cell 116(2):313–327
Akritas AG (1982) Reflections on a pair of theorems by Budan and Fourier. Math Mag 55(5):292–298
Brettschneider J, Tredici D, Kelly L, Virginia M-Y, Trojanowski JQ (2015) Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16(2):109–120
Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11(4):301–307
Byrne LJ, Cox BS, Cole DJ, Ridout MS, Morgan BJT, Tuite MF (2007) Cell division is essential for elimination of the yeast [\(PSI^+\)] prion by guanidine hydrochloride. Proc Natl Acad Sci 104(28):11688–11693
Calvez V, Lenuzza N, Doumic M, Deslys J-P, Mouthon F, Perthame B (2010) Prion dynamics with size dependency—strain phenomena. J Biol Dyn 4(1):28–42
Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268(5212):880–884
Chien P, Weissman JS, DePace AH (2004) Emerging principles of conformation-based prion inheritance. Annu Rev Biochem 73(1):617–656
Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24(1):519–550
Cox BS, Tuite MF, McLaughlin CS (1988) The \(psi\) factor of yeast: a problem in inheritance. Yeast 4(3):159–178
Crick FH (1958) On protein synthesis. In: Symposia of the society for experimental biology, vol 12, p 138
Davis JK, Sindi SS (2015) A study in nucleated polymerization models of protein aggregation. Appl Math Lett 40:97–101
Derdowski A, Sindi SS, Klaips CL, DiSalvo S, Serio TR (2010) A size threshold limits prion transmission and establishes phenotypic diversity. Science 330(6004):680–683
Doumic M, Gabriel P (2010) Eigenelements of a general aggregation–fragmentation model. Math Mod Method Appl Sci 20(05):757–783
Doumic M, Goudon T, Lepoutre T et al (2009) Scaling limit of a discrete prion dynamics model. Commun Math Sci 7(4):839–865
Doyle SM, Wickner S (2009) Hsp104 and ClpB: protein disaggregating machines. Trends Biochem Sci 34(1):40–48
Engler H, Prüss J, Webb GF (2006) Analysis of a model for the dynamics of prions II. J Math Anal Appl 324(1):98–117
Ferreira PC, Ness F, Edwards SR, Cox BS, Tuite MF (2001) The elimination of the yeast [\(PSI^+\)] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 40(6):1357–1369
Ghaemmaghami S, Huh W-K, Bower K, Howson RW, Belle A, Dephoure N, O’Shea EK, Weissman JS (2003) Global analysis of protein expression in yeast. Nature 425(6959):737–741
Goldberg AD, Allis CD, Bernstein E (2007) Epigenetics: a landscape takes shape. Cell 128(4):635–638
Greer ML, Pujo-Menjouet L, Webb GF (2006) A mathematical analysis of the dynamics of prion proliferation. J Theor Biol 242(3):598–606
Hartwell LH, Unger MW (1977) Unequal division in Saccharomyces cerevisiae and its implications for the control of cell division. J Cell Biol 75(2):422–435
Higurashi T, Hines JK, Sahi C, Aron R, Craig EA (2008) Specificity of the J-protein Sis1 in the propagation of 3 yeast prions. Proc Natl Acad Sci 105(43):16596–16601
Inoue Y, Taguchi H, Kishimoto A, Yoshida M (2004) Hsp104 binds to yeast Sup35 prion fiber but needs other factor (s) to sever it. J Biol Chem 279(50):52319–52323
Jackrel ME, Shorter J (2014) Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. Dis Mod Mech 7(10):1175–1184
Klaips CL, Hochstrasser ML, Langlois CR, Serio TR (2014) Spatial quality control bypasses cell-based limitations on proteostasis to promote prion curing. eLife 3:e04288
Knowles TPJ, Vendruscolo M, Dobson CM (2014) The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 15(6):384–396
Li MY, Graef JR, Wang L, Karsai J (1999) Global dynamics of a SEIR model with varying total population size. Math Biosci 160(2):191–213
Liebman SW, Chernoff YO (2012) Prions in yeast. Genetics 191(4):1041–1072
Masel J, Jansen VAA, Nowak MA (1999) Quantifying the kinetic parameters of prion replication. Biophys Chem 77(2):139–152
Nelson DL, Lehninger AL, Cox MM (2008) Lehninger principles of biochemistry. Macmillan, London
Nowak MA, Krakauer DC, Klug A, May RM (1998) Prion infection dynamics. Integr Biol Issue News Rev 1(1):3–15
Palmer KJ, Ridout MS, Morgan BJT (2011) Kinetic models of guanidine hydrochloride-induced curing of the yeast [PSI\(^+\)] prion. J Theor Biol 274(1):1–11
Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt–Jakob disease. Lancet Neurol 4(12):805–814
Prüss J, Pujo-Menjouet L, Webb G, Zacher R (2006) Analysis of a model for the dynamics of prions. Discr Contin Dyn Syst Ser B 6(1):225–235
Satpute-Krishnan P, Langseth SX, Serio TR (2007) Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance. PLoS Biol 5(2):e24
Segel LA, Slemrod M (1989) The quasi-steady-state assumption: a case study in perturbation. SIAM Rev 31(3):446–477
Shorter J, Lindquist S (2008) Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions. EMBO J 27(20):2712–2724
Sindi SS, Serio TR (2009) Prion dynamics and the quest for the genetic determinant in protein-only inheritance. Curr Opin Microbiol 12(6):623–630
Strbuncelj M (2009) The impact of genetic and epigenetic interactions on propagation of the [PSI+] prion. Ph.D. thesis, Brown University
Tanaka M, Collins SR, Toyama BH, Weissman JS (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442(7102):585–589
Tuite MF, Cox BS (2003) Propagation of yeast prions. Nat Rev Mol Cell Biol 4(11):878–890
Tuite MF, Serio TR (2010) The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 11(12):823–833
Wickner RB (1994) [\(URE3\)] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264(5158):566–569